What is the current antibody testing market size?

The antibody testing market size is approximately USD 2.5 billion as of 2023.

What is the growth forecast for the antibody testing market?

The market is expected to grow at a CAGR of 6.2% from 2023 to 2028.

What are the key drivers of the antibody testing market?

Increasing demand for diagnostic tests and rising awareness of infectious diseases drive the market.

What are the challenges faced by the antibody testing market?

High costs and limited accessibility in developing regions hinder market growth.

Which regions lead the antibody testing market?

North America and Europe dominate the market due to advanced healthcare infrastructure.

Who are the top companies in the antibody testing market?

Leading companies include Roche, Abbott, and Siemens, offering innovative diagnostic solutions.

What future opportunities exist in the antibody testing market?

Emerging markets and technological advancements in point-of-care testing present growth opportunities.

How does technology impact the antibody testing market?

Advances in molecular diagnostics and automation enhance test accuracy and efficiency.

What is the regulatory landscape for the antibody testing market?

Stringent regulations and standards ensure test quality and safety, shaping the future outlook.

antibody testing Market Metrics & Forecast Analysis 2033

antibody testing by Application (Hospital, Academic and Research Institutes, Diagnostic Laboratories, Biopharmaceutical Companies, Homecare Settings), by Types (Serological Test Kit, Immunoglobulin Kits, Lateral Flow Assay Kits), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $12450 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $12450 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

antibody testing Market Overview

The antibody testing market refers to the industry involved in the development and distribution of tests that detect specific antibodies in the blood. As the antibody testing market size is expected to witness significant growth, driven by an increasing demand for accurate and reliable diagnostic tests, the growth outlook and market forecast indicate a promising future for industry players. The industry expansion is anticipated to be fueled by advancements in technology, rising healthcare expenditure, and an growing awareness about the importance of early disease diagnosis. The scope of the antibody testing market encompasses various types of tests, including ELISA, Western blot, and rapid tests, which are used to diagnose and monitor a range of diseases, from infectious diseases to autoimmune disorders. According to recent estimates, the current antibody testing market size is approximately $3.5 billion, with a projected CAGR of around 8% during the forecast period.

Loading chart…

The antibody testing market is driven by several key forces, including technology shifts, such as the development of point-of-care tests, regulations, such as the increasing demand for regulatory compliance, and consumer behavior, such as the growing awareness about the importance of early disease diagnosis. The largest region in the antibody testing market is North America, while the fastest-growing region is Asia-Pacific. The market is expected to witness significant growth during the forecast period, driven by the increasing demand for accurate and reliable diagnostic tests, and the rising healthcare expenditure in emerging economies. As the industry continues to evolve, it is essential for market players to stay ahead of the curve, by investing in research and development, and expanding their product portfolios to cater to the changing needs of the market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.45 billion
Revenue forecast in 2033	32.63 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Abbott Laboratories; Bio-Rad Laboratories; Beckton, Dickinson and Company; F. Hoffmann-La Roche; Agilent Technologies; DiaSorin; Zeus Scientific; Abcam; Trinity Biotech; Werfen (Biokit); Promega; BioLegend; Meridian Bioscience; Bio-Techne (R&D Systems)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The antibody testing market is poised for significant growth, driven by increasing demand for diagnostic tests and advancements in technology. Understanding the dynamics of this market is crucial for stakeholders to capitalize on emerging opportunities and navigate challenges.

Growth Drivers2 items

Rising demand for diagnostic tests is fueling the growth of the antibody testing market, with the global market size expected to increase substantially over the forecast period.

Advancements in testing technologies, such as enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA), are improving test accuracy and contributing to the growth forecast of the antibody testing market.

Restraints2 items

Stringent regulatory requirements for the approval of new antibody testing kits are limiting the entry of new players in the market, thereby restraining the antibody testing market size.

High cost of testing is a significant barrier to the adoption of antibody tests, particularly in developing countries, which is affecting the overall growth forecast of the market.

Opportunities2 items

The increasing prevalence of infectious diseases is creating opportunities for the antibody testing market, as these tests are essential for diagnosing and monitoring diseases.

The growing demand for personalized medicine is driving the adoption of antibody tests, which can help tailor treatment to individual patient needs, thereby driving the antibody testing market forward.

Challenges2 items

The lack of standardization in antibody testing is a significant challenge, as it can lead to variations in test results and affect the accuracy of diagnoses, ultimately impacting the antibody testing market size.

The competition from alternative diagnostic technologies, such as molecular diagnostics, is a challenge for the antibody testing market, as these technologies may offer more accurate or rapid results, influencing the growth forecast.

Market Segmentation

Loading chart…

The application segment of the antibody testing market contributes significantly to the overall market size. This segment can be further divided into diagnostic and research applications. Diagnostic applications involve the use of antibody tests to diagnose infectious diseases, autoimmune disorders, and other conditions. Research applications, on the other hand, involve the use of antibody tests in various research settings, such as academia and pharmaceutical companies. Understanding the antibody testing segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

The types segment of the antibody testing market is another critical aspect of market taxonomy. This segment includes subtypes such as monoclonal and polyclonal antibodies. Monoclonal antibodies are produced by a single clone of cells and are highly specific, while polyclonal antibodies are produced by multiple clones of cells and are less specific. Each subtype has its own unique characteristics and applications, and understanding these differences is essential for developing effective antibody testing strategies. By analyzing the types segment, market players can identify areas of growth and develop targeted products and services to meet the evolving needs of the market.

antibody testing Segmentation Breakdown10 items

Application

Hospital

Academic and Research Institutes

Diagnostic Laboratories

Biopharmaceutical Companies

Homecare Settings

Types

Serological Test Kit

Immunoglobulin Kits

Lateral Flow Assay Kits

Regional Insights

Loading chart…

The antibody testing market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, increasing adoption of point-of-care testing, and a growing geriatric population. Asia Pacific's growth is driven by rising healthcare expenditure, expanding middle-class population, and increasing access to healthcare services. Latin America's growth is driven by improving economic conditions, increasing healthcare investments, and a growing awareness of chronic diseases. The Middle East & Africa region is driven by government initiatives, increasing private sector investments, and a growing demand for advanced diagnostic services.

The regional forecast indicates that Asia Pacific will experience significant antibody testing market growth, driven by the region's large and growing population, increasing disease prevalence, and rising demand for diagnostic services. As the market continues to evolve, understanding regional trends and drivers will be crucial for stakeholders to navigate the antibody testing market and capitalize on emerging opportunities.

Competitive Landscape

The antibody testing market is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the antibody testing competitive landscape is crucial for navigating this complex market, where companies must balance product differentiation with cost pressures.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Thermo Fisher Scientific: regional expansion

Abbott Laboratories: innovation pipeline

Bio-Rad Laboratories: premium pricing

Beckton, Dickinson and Company: OEM tie-ups

F. Hoffmann-La Roche: local manufacturing

Agilent Technologies: vertical integration

Key antibody testing Companies15 items

Thermo Fisher Scientific

Abbott Laboratories

Bio-Rad Laboratories

Beckton, Dickinson and Company

F. Hoffmann-La Roche

Agilent Technologies

DiaSorin

Zeus Scientific

Abcam

Trinity Biotech

Werfen (Biokit)

Promega

BioLegend

Meridian Bioscience

Bio-Techne (R&D Systems)

Market Ecosystem

The antibody testing ecosystem spans across upstream, midstream, and downstream activities, involving various stakeholders who contribute to the creation and delivery of antibody testing solutions. Technology providers and suppliers form the upstream segment, while integrators and manufacturers constitute the midstream. The downstream segment comprises channels, such as distributors and channel partners, and end users, including healthcare providers and research institutions. Value is created and captured through the development, manufacturing, and distribution of antibody testing products and services.

Raw material suppliers — providing reagents and consumables

Technology providers — developing assay platforms and software

OEMs / manufacturers — producing testing equipment and kits

System integrators / EPCs — integrating testing systems and infrastructure

Distributors / channel partners — supplying testing products to end users

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing testing standards and guidelines

In the antibody testing ecosystem, control points are influenced by regulators and standards bodies, who set guidelines and approvals for testing products. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the adoption of new testing technologies. Switching costs and partnerships between stakeholders can also affect the ecosystem, particularly in terms of interoperability requirements. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and market requirements, highlighting the need for a thorough value chain analysis to understand the intricacies of the antibody testing ecosystem.

Recent Industry Insights

The antibody testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between leading diagnostic companies to develop innovative antibody testing solutions, have been instrumental in driving growth. Furthermore, mergers and acquisitions, like the acquisition of specialized testing firms, have enabled companies to expand their portfolios and strengthen their market presence.

Additionally, the launch of advanced testing technologies has improved the accuracy and efficiency of antibody testing. Regulatory changes, such as the approval of new testing protocols, have also contributed to the evolution of the industry. The antibody testing industry trends are expected to continue shifting in response to changing consumer and enterprise trends, with a growing demand for rapid and reliable testing solutions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the antibody testing market. The market attractiveness is moderate, driven by increasing demand for diagnostic tests. The competitive intensity is high, with several major players competing for market share. The long-term antibody testing market outlook is promising, with opportunities for growth in emerging markets. The innovation landscape is rapidly evolving, with advancements in technology and testing methods. However, the demand-supply balance is a concern, with potential risks of supply chain disruptions and regulatory challenges. Key risk factors include market volatility and intense competition.

11 items

1. Executive Summary

2. antibody testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global antibody testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global antibody testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Academic and Research Institutes

6.1.3. Diagnostic Laboratories

6.1.4. Biopharmaceutical Companies

6.1.5. Homecare Settings

6.2. Global antibody testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Serological Test Kit

6.2.2. Immunoglobulin Kits

6.2.3. Lateral Flow Assay Kits

6.3. Global antibody testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global antibody testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global antibody testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global antibody testing Market Competition by Key Manufacturers

8.1. Global antibody testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global antibody testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Rad Laboratories

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Beckton, Dickinson and Company

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. F. Hoffmann-La Roche

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Agilent Technologies

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. DiaSorin

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Zeus Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Abcam

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Trinity Biotech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Werfen (Biokit)

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Promega

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. BioLegend

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Meridian Bioscience

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Bio-Techne (R&D Systems)

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global antibody testing Market

Figure 4: Global antibody testing Market: Drivers

Figure 5: Global antibody testing Market: Challenges

Figure 6: Global antibody testing Market: Trends

Figure 7: Global antibody testing Market: Opportunity

Figure 8: Global antibody testing Market: Restraint

Figure 9: Global antibody testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global antibody testing Market Value (USD Million) By Region

Figure 15: Global antibody testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global antibody testing Market Value (USD Million) By Region

Figure 23: Global antibody testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global antibody testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global antibody testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global antibody testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global antibody testing Market Value (USD Million) By Region

Table 10: Global antibody testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global antibody testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global antibody testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global antibody testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Abbott Laboratories Basic Information And Sales Area

Table 33: Abbott Laboratories. Products Portfolio

Table 34: Bio-Rad Laboratories Basic Information And Sales Area

Table 35: Bio-Rad Laboratories. Products Portfolio

Table 36: Beckton, Dickinson and Company Basic Information And Sales Area

Table 37: Beckton, Dickinson and Company. Products Portfolio

Table 38: F. Hoffmann-La Roche Basic Information And Sales Area

Table 39: F. Hoffmann-La Roche. Products Portfolio

Table 40: Agilent Technologies Basic Information And Sales Area

Table 41: Agilent Technologies. Products Portfolio

Table 42: DiaSorin Basic Information And Sales Area

Table 43: DiaSorin. Products Portfolio

Table 44: Zeus Scientific Basic Information And Sales Area

Table 45: Zeus Scientific. Products Portfolio

Table 46: Abcam Basic Information And Sales Area

Table 47: Abcam. Products Portfolio

Table 48: Trinity Biotech Basic Information And Sales Area

Table 49: Trinity Biotech. Products Portfolio

Table 50: Werfen (Biokit) Basic Information And Sales Area

Table 51: Werfen (Biokit). Products Portfolio

Table 52: Promega Basic Information And Sales Area

Table 53: Promega. Products Portfolio

Table 54: BioLegend Basic Information And Sales Area

Table 55: BioLegend. Products Portfolio

Table 56: Meridian Bioscience Basic Information And Sales Area

Table 57: Meridian Bioscience. Products Portfolio

Table 58: Bio-Techne (R&D Systems) Basic Information And Sales Area

Table 59: Bio-Techne (R&D Systems). Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global antibody testing Market Value (USD Million) By Region

Table 65: Global antibody testing Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

antibody testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.45 billion
Revenue forecast in 2033	32.63 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Abbott Laboratories; Bio-Rad Laboratories; Beckton, Dickinson and Company; F. Hoffmann-La Roche; Agilent Technologies; DiaSorin; Zeus Scientific; Abcam; Trinity Biotech; Werfen (Biokit); Promega; BioLegend; Meridian Bioscience; Bio-Techne (R&D Systems)
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for diagnostic tests is fueling the growth of the antibody testing market, with the global market size expected to increase substantially over the forecast period.

Restraints2 items

Stringent regulatory requirements for the approval of new antibody testing kits are limiting the entry of new players in the market, thereby restraining the antibody testing market size.

High cost of testing is a significant barrier to the adoption of antibody tests, particularly in developing countries, which is affecting the overall growth forecast of the market.

Opportunities2 items

The increasing prevalence of infectious diseases is creating opportunities for the antibody testing market, as these tests are essential for diagnosing and monitoring diseases.

Challenges2 items

Market Segmentation

Loading chart…

antibody testing Segmentation Breakdown10 items

Application

Hospital

Academic and Research Institutes

Diagnostic Laboratories

Biopharmaceutical Companies

Homecare Settings

Types

Serological Test Kit

Immunoglobulin Kits

Lateral Flow Assay Kits

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific: regional expansion

Abbott Laboratories: innovation pipeline

Bio-Rad Laboratories: premium pricing

Beckton, Dickinson and Company: OEM tie-ups

F. Hoffmann-La Roche: local manufacturing

Agilent Technologies: vertical integration

Key antibody testing Companies15 items

Thermo Fisher Scientific

Abbott Laboratories

Bio-Rad Laboratories

Beckton, Dickinson and Company

F. Hoffmann-La Roche

Agilent Technologies

DiaSorin

Zeus Scientific

Abcam

Trinity Biotech

Werfen (Biokit)

Promega

BioLegend

Meridian Bioscience

Bio-Techne (R&D Systems)

Market Ecosystem

Raw material suppliers — providing reagents and consumables

Technology providers — developing assay platforms and software

OEMs / manufacturers — producing testing equipment and kits

System integrators / EPCs — integrating testing systems and infrastructure

Distributors / channel partners — supplying testing products to end users

Service providers / after-sales — offering maintenance and support services

Regulators/standards bodies — establishing testing standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents